Dr. Heng elaborates the two clinical factors and four lab criteria of the International Metastatic RCC Database Consortium (IMDC) risk model and how this model can be used for metastatic renal cell carcinoma prognosis.
Related article: Outcome of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium